Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020)
Background. Systemic sclerosis (Ssc) is an autoimmune disease characterized by graduate cutaneous and tissue fibrosis development and irreversible fibroproliferative vascular changes.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Sciendo,
2021-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_b4901b9b3f0a49d4b9cc77ebf03f0baf | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Bălănescu Paul |e author |
| 700 | 1 | 0 | |a Bălănescu Anca |e author |
| 700 | 1 | 0 | |a Bălănescu Eugenia |e author |
| 700 | 1 | 0 | |a Băicuş Cristian |e author |
| 245 | 0 | 0 | |a Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020) |
| 260 | |b Sciendo, |c 2021-06-01T00:00:00Z. | ||
| 500 | |a 2501-062X | ||
| 500 | |a 10.2478/rjim-2020-0037 | ||
| 520 | |a Background. Systemic sclerosis (Ssc) is an autoimmune disease characterized by graduate cutaneous and tissue fibrosis development and irreversible fibroproliferative vascular changes. | ||
| 546 | |a EN | ||
| 690 | |a systemic sclerosis | ||
| 690 | |a biomarker | ||
| 690 | |a proteomic | ||
| 690 | |a mass spectrometry | ||
| 690 | |a validation | ||
| 690 | |a Internal medicine | ||
| 690 | |a RC31-1245 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Romanian Journal of Internal Medicine, Vol 59, Iss 2, Pp 101-111 (2021) | |
| 787 | 0 | |n https://doi.org/10.2478/rjim-2020-0037 | |
| 787 | 0 | |n https://doaj.org/toc/2501-062X | |
| 856 | 4 | 1 | |u https://doaj.org/article/b4901b9b3f0a49d4b9cc77ebf03f0baf |z Connect to this object online. |